A novel approach to glioma gene therapy: Down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes

International Journal of Oncology

Volumn 12, Issue 6, 1998, Pages 1391-1396

  Ke, Li Dao ^a   Fueyo, Juan ^a   Chen, Xiashan ^a   Steck, Peter A ^a   Shi, Yue Xi ^a   Im, Seock Ah ^a   Yung, W K Alfred ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Gene therapy; Glioma; Ribozymes; Vascular endothelial growth factor

Indexed keywords

RIBOZYME; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0042966942     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.6.1391     Document Type: Article

References (20)

1. Brem S, Cotram R and Folkman J: Tumor angiogenesis: a quantitative method for histological grading. J Natl Cancer Inst 48: 347-356, 1972.
2. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM and Deder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478, 1989.
3. Ferrara N and Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989.
4. Folkman J and Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
5. Battegay EJ: Angiogenesis: mechanistic insights, neovascular disease and therapeutic prospects. J Mol Med 73: 333-346, 1995.
6. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM and Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 79: 233-269, 1997.
7. Plate KH and Risau VV: Angiogenesis in malignant gliomas. Glia 15: 339-347, 1995.
8. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, and Nose T: Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56: 2185-2190, 1996.
9. Benjamin LE and Keshet E: Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastomalike vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94: 8761-8766, 1997.
10. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips S and Ferrara N: Inhibition of VEGF-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844, 1993.
11. Borgstrom P, Hillan KJ, Sriramarao P and Ferrara N: Complete inhibition of angiogenesis and growth of microtumors by anti-VEGF neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56: 4032-4039, 1996.
12. Saleh M, Stacker SA and Wilks AF: Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401, 1996.
13. Cheng S-Y, Su Huang H-J, Nagane M, Ji X-D, Wang D, Shih CC-Y, Arap W, Huang C-M and Cavenee WK: Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93: 8502-8507, 1996.
14. Narlikar GJ and Herschlag D: Mechanistic aspects of enzymatic catalysis: lessons from comparison of RNA and protein enzymes. Annu Rev Biochem 66: 19-59, 1997.
15. Haseloff J and Gerlach WL: Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585-591, 1988.
16. Birikh KR, Heaton PA and Eckstein F: The structure, function and application of the hammerhead ribozyme. Eur J Biochem 245: 1-6, 1997.
17. Bertrand E, Castanotto D, Zhou C, Carbonnelle C, Lee NS, Good P, Cahtterjee S, Grange T, Pictet R, Kohn D, Engelke D, and Rossi JJ: The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 3: 75-88, 1997.
18. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
19. Green S, Issemann I and Sheer E: A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16: 363, 1988.
20. Ke LD, Adler-Storthz K, Clayman GL, Yung WKA and Chen Z: Differential expression of epidermal growth factor receptor in human head and neck cancers. Head Neck (In press).